Industry Sponsored Session| Presentation by Incyte Intervening with Jakafi® (ruxolitinib) to Achieve Durable Count Control: Real-World Patient Case Discussion | Focus on Adults with Polycythemia Vera Who Have an Inadequate Response to Hydroxyurea

Player size: small large

0 0

AONN+ Midyear 2021 Virtual Conference

SAT03 - Industry Sponsored Session| Presentation by Incyte Intervening with Jakafi® (ruxolitinib) to Achieve Durable Count Control: Real-World Patient Case Discussion | Focus on Adults with Polycythemia Vera Who Have an Inadequate Response to Hydroxyurea

May 15, 2021 10:00am ‐ May 15, 2021 11:00am

Overview
Comments

Speaker(s):

Christopher Nelson, MSN, ACNP-BC, MBA, Avera Medical Group Oncology & Hematology Aberdeen

You must be logged in and own this session in order to post comments.

Item	Price	Remove